SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Dolutegravir Resistance in Resource-Limited Settings
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|
Session Overview - Dolutegravir Resistance in Resource-Limited Settings
Gert U. van Zyl
Stellenbosch University, Cape Town, South Africa
Viremia and Drug Resistance 2 Years After Routine Switching to Dolutegravir-Based First-Line ART (ABSTRACT
676)
Richard J. Lessells
KwaZulu-Natal Research Innovation and Sequencing Platform, KRISP
DTG Resistance in Patients with Previous ARV Experience and Viremia in Kenya Receiving DTG-Based ART (ABSTRACT
677)
Leonard Kingwara
Ministry of Health, Nairobi, Kenya
Emerging Dolutegravir Resistance in Lesotho (ABSTRACT
678)
Niklaus D. Labhardt
University of Basel, Basel, Switzerland
Resistance to Second-Generation InSTIs in Mexican PLWH: Emergence of the R263K Mutant (ABSTRACT
679)
Luis Enrique Soto Ramírez
incmnsz
Virologic Outcomes With Tenofovir-Lamivudine-Dolutegravir for PI-Based Second-Line ART Failure (ABSTRACT
680)
Ying Zhao
University of Cape Town, Cape Town, South Africa
Discussion with Audience Questions and Answers
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|